Neonc Technologies Holdings (NTHI) Payables (2024 - 2026)
Neonc Technologies Holdings (NTHI) posted quarterly Payables of $2.5 million for Q1 2026, down 38.71% year-over-year from $4.0 million in Q1 2025, and down 13.67% quarter-over-quarter from $2.9 million in Q4 2025.
Neonc Technologies Holdings (NTHI) Payables (2024 - 2026) Analysis & Trends
Neonc Technologies Holdings (NTHI) has reported Payables for 3 consecutive years, with $2.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Payables fell 38.71% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $2.5 million (down 38.71% YoY), while the FY2025 annual figure was $2.9 million, down 1.23% from the prior year.
- Payables fell to $2.5 million in Q1 2026 per NTHI's latest filing, from $2.9 million in the prior quarter.
- Across five years, Payables topped out at $4.0 million in Q1 2025 and bottomed at $1.6 million in Q3 2025.
- Historically, Payables has averaged $2.8 million across 3 years, with a median of $2.9 million in 2024.
- Annual changes were most pronounced in 2025 — Payables declined 1.23% — and 2026, when it sank 38.71%.
- Neonc Technologies Holdings' Payables stood at $2.9 million in 2024, then declined by 1.23% to $2.9 million in 2025, then retreated by 13.67% to $2.5 million in 2026.
- Business Quant data shows NTHI's Payables at $2.5 million in Q1 2026, $2.9 million in Q4 2025, and $1.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Neonc Technologies Holdings | 116.41 Mn | 116.41 Mn | - | 5.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.09 Mn |
| Mar 31, 2026 | 2.47 Mn |
| Dec 31, 2025 | 2.86 Mn |
| Sep 30, 2025 | 1.64 Mn |
| Jun 30, 2025 | 3.07 Mn |
| Mar 31, 2025 | 4.03 Mn |
| Dec 31, 2024 | 2.89 Mn |